The pathological response to Cryptococcus invasion varies widely, ranging from a lack of response in severely immunocompromised patients to the development of a robust granulomatous response—a reaction considered central to the host's ability to contain the infection. Clinical disease caused by Cryptococcus neoformans in organ transplant recipients typically manifests more than six months post-transplantation. A major exception to this general pattern involves patients who, prior to the transplant, had a history of immunosuppression due to an underlying condition or had previously undergone a failed transplant. The most common post-transplant presentation of cryptococcosis is an asymptomatic pulmonary nodule discovered incidentally on chest imaging.
Diagnosing this disease typically requires a biopsy, as antigen test results are often negative in such cases; additionally, evaluating transplant patients for Cryptococcus infection involving other body sites—including the central nervous system, skin, prostate, and skeletal system—is recommended. Cryptococcal pneumonia may also occur, presenting a spectrum of conditions ranging from asymptomatic cases to severe respiratory impairment.
Pulmonary disease—whether manifesting as frank pneumonia or merely as a solitary nodule—may occur despite a negative serum cryptococcal antigen test; consequently, definitive diagnosis requires more invasive procedures, such as bronchoscopy or biopsy. A critical factor in cryptococcal infection is whether hematogenous dissemination occurs and, if so, the likelihood of central nervous system involvement.
The risk factors predisposing individuals to infection by Mucorales fall into three main categories of abnormalities: immunosuppression, metabolic disorders, and skin and soft-tissue injury. Clinical syndromes caused by fungi of the order Mucorales are characterized by angioinvasion—leading to necrosis, infarction, and hemorrhage—rapid progression, and relative resistance to available antifungal drugs. The most common forms of these syndromes are the rhino-cerebral, pulmonary, cutaneous and soft-tissue, and disseminated forms. Compared to Aspergillus infections, mucoralean fungi less frequently cause disseminated disease, but their spread to adjacent structures is much more rapid. Rhino-cerebral zygomycosis affects the nose, sinuses, eyes, and brain, in that order.
Early symptoms include nasal congestion, epistaxis, sinus tenderness, retro-orbital headache, and localized swelling. As the condition progresses, swelling of the affected tissues becomes more pronounced, ocular symptoms emerge, and cutaneous sensory loss occurs due to nerve infarction. Diagnosing zygomycosis requires pathological evaluation or culture. Performing a biopsy of the necrotizing infected areas during the early stages is critically important. One of our guiding principles in evaluating immunocompromised patients is that no necrotic lesion should go unbiopsied, as it could be the initial clinical manifestation of these fungi or other angioinvasive molds.
|
